Document:

Exhibit 10.19

 

Eastern Virginia Bankshares, Inc. (the
“Company”)

Schedule of Non-Employee Directors’
Annual Compensation

 

Effective May 19, 2016

 

	Meeting Fees (1)(2)(3)	 	 	 	 
	Per Company Board Meeting	 	$	450	 
	Per Company Committee Meeting	 	$	450	 
	Per EVB Board Meeting	 	$	750	 
	Per EVB Committee Meeting (4)	 	$	450	 

 

	Monthly Retainers	 	 	 	 
	Chairman of the Company’s Audit and Risk Oversight Committee	 	$	450	 
	Other members of the Company’s Audit and Risk Oversight Committee	 	$	300	 
	Chairman of the EVB Board	 	$	750	 

 

	Annual stock grant to non-employee directors (5):	grant of unrestricted shares of common stock on July 1 annually with grant date value of $15,000.

 

(1)     Each director of the Company’s Board of Directors
is also a member of the Board of Directors of EVB. 

(2)     For meetings of the Company’s Board of Directors
and EVB’s Board of Directors, directors are permitted one paid absence per year.

(3)     For joint meetings of the Company’s Board of
Directors and EVB’s Board of Directors, for the Company meeting each director of the Company will receive a fee of $225,
rather than a meeting fee of $450. The Chairman of the Company’s Board of Directors may, in his sole discretion, determine
to pay each director of the Company the standard meeting fee of $450, rather than $225. Each member of EVB’s Board of Directors
would still receive an EVB meeting fee of $750.

(4)     Each member of the Loan Committee of EVB receives
$225 for each teleconference of the Loan Committee between regularly scheduled Loan Committee meetings.

(5)     The number of shares granted shall be based on the
closing price of the Company’s common stock on the date of grant and prorated to the time served.Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

This Employment
Agreement (this “Agreement”) is made and entered into on May 9, 2016 and effective as of April 21, 2016
(the “Effective Date”), by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation with a
place of business at 5600 Blazer Parkway, Suite 200, Dublin, Ohio 43017-7550 (the “Company”), and Jed A. Latkin,
residing at 340 West 86th Street, Apt. 6B, New York, New York 10024 (“Executive”). The Company
and Executive are hereinafter sometimes collectively referred to as the “Parties.”

  

WHEREAS, the Company
has offered to employ Executive as interim Chief Operating Officer, and the Executive desires to accept such employment; and

 

WHEREAS, the Parties
wish to establish terms, covenants, and conditions for Executive’s employment with the Company through this Employment Agreement.

 

NOW, THEREFORE, in
consideration of the mutual agreements herein set forth, the Parties agree as follows:

 

1.                 
Position and Duties. From and after the Effective Date, and based upon the terms and conditions set forth herein, the Company
agrees to employ the Executive and the Executive agrees to be employed by the Company, as the Company’s interim Chief Operating
Officer and/or in such other position or positions as shall be assigned to him by the Company’s Board of Directors (the “Board”).
While serving as interim Chief Operating Officer, the Executive shall report directly to the Board. The Executive shall have such
management, supervisory and operational functions and other powers, functions and duties as may from time to time be prescribed
by the Board. During the Term of this Agreement (as defined in Section 2 below), the Executive agrees to devote substantially all
of his business time to the positions he holds with the Company and to faithfully, industriously, and to the best of his ability,
experience and talent, perform the duties that are assigned to him. The Executive shall also observe and abide by the reasonable
corporate policies and decisions of the Company in all business matters.

 

2.                 
Term. This Agreement shall be in effect from April 21, 2016. The Company and Executive agree that Executive’s employment
with the Company is for no specified period of time and constitutes “at will” employment. As such, either Party may
terminate this Agreement and Executive’s employment relationship with the Company at any time, without notice and for any
reason with or without cause. The provisions of Sections 5 and 6 shall survive any termination of this Agreement. The term of Executive’s
employment under this Agreement is referred to herein as the “Term.” 

 

3.                 
Compensation.

 

(a)               
Salary. During the Term, the Executive shall receive a monthly salary (the “Monthly Salary”) of $15,000
during the first and second months following the Effective Date, $17,500 during the third and fourth months following the Effective
Date and $20,000 per month thereafter, which Monthly Salary shall be paid in accordance with the Company’s normal payroll
procedures. The Board may evaluate the Monthly Salary from time to time and increase such salary in its sole discretion.

 

     

     

    

 

(b)              
Stock Options. Executive acknowledges that, on the Effective Date, the Company granted Executive a stock option to purchase
45,000 shares of common stock of the Company at an exercise price of $1.50 per share. Such stock options vest and become exercisable
in equal monthly installments of 7,500 shares over a period of six consecutive months commencing on the one month anniversary of
the Effective Date and shall have a term of ten years, subject to earlier termination as specified in the stock option and/or the
Company’s related 2014 Stock Incentive Plan. After a period of six months, the Company will consider, in its sole discretion,
granting additional stock options to Executive.

 

4.                 
Expenses. The Company shall reimburse the Executive for all reasonable out-of-pocket expenses incurred by him in the performance
of his duties hereunder, including expenses for travel and similar items, promptly after presentation by the Executive, from time
to time, of an itemized account of such expenses.

 

5.                 
Proprietary Information Agreement. Executive has executed a Proprietary Information Agreement as a condition of employment
with the Company. The Proprietary Information Agreement shall not be limited by this Agreement in any manner, and the Executive
shall act in accordance with the provisions of the Proprietary Information Agreement at all times.

 

6.                 
Non-Competition; Non-Solicitation: Non-Interference. Executive agrees that for so long as he is employed by the Company
and for a period of one (1) year following termination of his employment for any reason (the “Restricted Period”),
Executive will not:

 

(a)               
engage, on his own behalf or on behalf of any other person or entity, in any capacity, including, without limitation, as a director,
officer, employee, agent, consultant or representative, or have any ownership interest in any person or entity that engages (directly
or indirectly), in any activities which are the same or similar as, or in competition with, the business of the Company and the
activities carried on by the Company at any time during Employee’s employment with the Company;

 

(b)              
solicit for employment any person who is employed by the Company as of or subsequent to the Effective Date or who was employed
by the Company within the twelve (12) months immediately preceding the Effective Date; or

 

(c)               
solicit, induce, encourage or attempt to influence any client or customer, consultant, independent contractor, vendor or supplier
of the Company to cease to do, or reduce the amount of business done with, the Company following the Effective Date.

 

7.                 
Representations, Warranties and Agreements. Executive represents and warrants that he is free to enter into this Agreement
and to perform the duties required hereunder, and that there are no employment contracts or understandings, restrictive covenants
or other restrictions, whether written or oral, preventing the performance of his duties hereunder.

 

8.                 
Successors: Binding Agreement. This Agreement and all rights of Executive hereunder shall inure to the benefit of, and shall
be enforceable by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees,
devisees and legatees.

 

    	 	2	 

     

    

 

9.                 
Notice. For purposes of this Agreement, notices, demands and all other communications provided for in the Agreement shall
be in writing and shall be deemed to have been duly given when hand delivered or three (3) days after being mailed by United States
registered or certified mail, return receipt requested, postage prepaid, addressed to either Party at the address set forth hereinabove
or to such other address as either Party may have furnished to the other in writing in accordance herewith.

 

10.             
Amendments and Waivers. No provisions of this Agreement may be modified, waived or discharged unless such waiver, modification
or discharge is agreed to in writing and signed by Executive and such officers of the Company as may be specifically designated
by the Board. No waiver by either Party hereto at any time of any breach by the other Party hereto of, or compliance with, any
condition or provision of this Agreement to be performed by such other Party shall be deemed a waiver of similar or dissimilar
provisions or conditions at the same or at any prior or subsequent time.

 

11.             
Validity. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity
or enforceability of any other provision of this Agreement, which shall remain in full force and effect.

 

12.             
Entire Agreement. This Agreement, and the Proprietary Information Agreement referred to herein, sets forth the entire agreement
and understanding of the Parties hereto in respect of the subject matter contained herein. There are no promises, covenants, arrangements,
communications, representations or warranties, whether oral or written, between the Parties or by any officer, employee or representative
of any Party hereto or any predecessor of any Party hereto other than those that are expressly contained herein.

 

13.             
Non-assignability. This Agreement is entered into in consideration of the personal qualities of Executive and may not be,
nor may any right or interest hereunder be, assigned by him without the prior written consent of Company. It is expressly understood
and agreed that this Agreement, and the rights accruing and obligations owed to the Company hereunder, and the obligations to be
performed by the Company hereunder, may be assigned by the Company to any of its successors or assigns.

 

14.             
Choice of Law and Forum. This Agreement shall be governed by and construed in accordance with the laws of the State of New
York without giving effect to the principles of choice of law or conflicts of laws. Any action or proceeding arising out of or
relating to this Agreement shall be brought exclusively in the state or federal courts located in New York, New York, and each
of the Parties irrevocably submits to the jurisdiction of each such court in any such action or proceeding, waives any objection
he or it may now or hereafter have to venue or to convenience of forum, agrees that all claims in respect of the action or proceeding
shall be heard and determined only in any such court and agrees not to bring any action or proceeding arising out of or relating
to this Agreement in any other court. The Parties agree that either or both of them may file a copy of this Section with any court
as written evidence of the knowing, voluntary and bargained for agreement between the Parties irrevocably to waive any objections
to venue or to convenience of forum. Process in any action or proceeding referred to in the first sentence of this Section may
be served on any of the Parties anywhere in the world.

 

    	 	3	 

     

    

 

15.             
Waiver of Jury Trial. THE PARTIES HEREBY UNCONDITIONALLY WAIVE THEIR RESPECTIVE RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE
OF ACTION ARISING DIRECTLY OR INDIRECTLY OUT OF, RELATED TO, OR IN ANY WAY CONNECTION WITH THE PERFORMANCE OR BREACH OF THIS AGREEMENT,
AND/OR THE RELATIONSHIP THAT IS BEING ESTABLISHED BETWEEN THEM. The scope of this waiver is intended to be all encompassing of
any and all disputes that may be filed in any court or other tribunal (including, without limitation, contract claims, tort claims,
breach of duty claims, and all other common law and statutory claims). THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED
EITHER ORALLY OR IN WRITING, AND THE WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS, OR MODIFICATIONS TO
THIS AGREEMENT AND RELATED DOCUMENTS. In the event of litigation, this Agreement may be filed as written consent to a trial by
the court.

 

16.             
Headings. The Section headings appearing in this Agreement are for the purposes of easy reference and shall not be considered
a part of this Agreement or in any way modify, demand or affect its provisions.

 

17.             
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original
but all of which together shall constitute one and the same instrument.

  

 

[signature page follows]

 

    	 	4	 

     

    

 

IN WITNESS WHEREOF, the
Parties hereto have executed this Agreement on the day and year first-above written.

 

	 	/s/ Jed. A. Latkin
	 	Jed A. Latkin
	 	 	 
	 	Navidea Biopharmaceuticals, Inc.
	 	 	 
	 	By: 	/s/ Jed A. Latkin
	 	Name: Jed A. Latkin
	 	Title: Interim Chief Operating Officer
	 	(as Authorized by the Board of Directors)

 

    	 	5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}]]